Maybe the "going concern" will motivate Nasrat to sell some Norco and Percocet. We spent a million bucks filing the Tylenol/Codeine ANDA while Norco and Percocet are already approved and sit collecting dust. Maybe the auditor is doing us all a favor by calling his attention to the chronically negative cash flow while he sits on his hands (and our approved ANDA's).
News 
Market Data 
Discover 
